Hitchin, UK, 8TH NOVEMBER  Quanticate, a global data-focused clinical research organisation (CRO), has announced plans for further expansion and new jobs in 2023 as it thrives post-pandemic. 

The UK-headquartered firm opened its Toronto office in 2019 to facilitate the increasing customer base in the North American market. Since opening, it has seen its team double in size in the last year.

Now the firm is expanding further with plans for a number of additional jobs in the next year across the business. 

 “Our North American team of highly qualified statisticians and programmers have worked exceptionally hard and delivered excellent results. Market demand for our services skyrocketed post-pandemic which led us to commit to strengthening our North American team to ensure we continued to deliver our exceptional operations, stats and programming services to our existing and new customers” commented David Underwood, CEO of Quanticate. 

Underwood continued: “Our team expansion in Canada meets the growing demand from clients in the North American market to help form effective and efficient partnerships.”

“I’m delighted that our world-class services attract some of the best talent in the industry and I look forward to continuing to successfully deliver high-quality data-focused services.” 

Quanticate is one of the world’s largest global data-focused clinical research organizations (CROs) with a primary focus on data capture, statistical analysis, and clinical trial reporting. Find out more about the business and its service offerings here. 

ENDS

About Quanticate 

Quanticate is one of the world’s largest global data-focused clinical research organizations (CROs) with a primary focus on data capture, statistical analysis, and clinical trial reporting. As an expert in clinical data, Quanticate can rapidly provide high-quality teams that offer flexible solutions for clinical data management, biostatistics, statistical programming, pharmacokinetic/pharmacodynamic (PK/PD) analysis, medical writing, and statistical consultancy.

Quanticate meets the needs of drug‑ and device‑development companies by offering customer‑focused resource solutions from fixed‑cost or functional‑service‑provider (FSP) models through to consultancy. Quanticate has become the trusted supplier of choice for many companies from niche biotechnology and device companies to top tier pharmaceutical giants.

Media contact

Ramarketing PR

Danny McIver- daniel.mciver@ramarketingpr.com